Merck (MRK): Is There Still Value After the Recent Share Price Rally?
YahooSimply Wall St
Merck (MRK): Is There Still Value After the Recent Share Price Rally?
Merck (MRK) shares have ticked higher this week, catching the interest of investors who follow the big names in healthcare. The company's performance over the past month has been relatively steady. This stability invites a closer look at what might be driving sentiment. See our latest analysis for Merck. Merck’s momentum has picked up ...
3 days ago
Pembrolizumab Uses
Neoadjuvant Pembrolizumab for Lung Cancer | NEJM
2:13
Neoadjuvant Pembrolizumab for Lung Cancer | NEJM
YouTubeNEJM Group
4.2K viewsAug 10, 2023
Overall Survival with Pembrolizumab in Breast Cancer | NEJM
2:27
Overall Survival with Pembrolizumab in Breast Cancer | NEJM
YouTubeNEJM Group
2.4K views11 months ago
Keytruda (pembrolizumab): Uses, How It Works, and Common Side Effects - Drugs.com
1:19
Keytruda (pembrolizumab): Uses, How It Works, and Common Side Effects - Drugs.com
YouTubeDrugs.com
4.2K views9 months ago
Top videos
Merck’s blockbuster-to-be cardiovascular drug scores in another heart study
Merck’s blockbuster-to-be cardiovascular drug scores in another heart study
YahooJacob Bell
4 days ago
Merck on Instagram: "Merck has been integral to the transformation of the treatment of cardiovascular disease. The American Chemical Society has awarded our company a National Historic Chemical Landmark for our landmark research developing a medication to help lower LDL cholesterol. This designation recognizes the pioneering science that began with our team’s discovery and paved the way for first-in-class and follow-on medicines."
0:33
Merck on Instagram: "Merck has been integral to the transformation of the treatment of cardiovascular disease. The American Chemical Society has awarded our company a National Historic Chemical Landmark for our landmark research developing a medication to help lower LDL cholesterol. This designation recognizes the pioneering science that began with our team’s discovery and paved the way for first-in-class and follow-on medicines."
Instagrammerck
857 views1 day ago
Merck Drops, Walmart Falls, Nvidia Shares Set for Decline Ahead of Earnings | Stock Movers
4:16
Merck Drops, Walmart Falls, Nvidia Shares Set for Decline Ahead of Earnings | Stock Movers
YouTubeBloomberg Podcasts
5 views1 week ago
Pembrolizumab Side Effects
Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Cancer | NEJM
2:23
Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Cancer | NEJM
YouTubeNEJM Group
4K viewsMar 7, 2024
Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
2:05
Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
YouTubeNEJM Group
11.4K viewsMar 16, 2017
Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer
7:32
Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer
YouTubeecancer
65 views2 months ago
Merck’s blockbuster-to-be cardiovascular drug scores in another heart study
Merck’s blockbuster-to-be cardiovascular drug scores in ano…
4 days ago
YahooJacob Bell
Merck on Instagram: "Merck has been integral to the transformation of the treatment of cardiovascular disease. The American Chemical Society has awarded our company a National Historic Chemical Landmark for our landmark research developing a medication to help lower LDL cholesterol. This designation recognizes the pioneering science that began with our team’s discovery and paved the way for first-in-class and follow-on medicines."
0:33
Merck on Instagram: "Merck has been integral to the transformatio…
857 views1 day ago
Instagrammerck
Merck Drops, Walmart Falls, Nvidia Shares Set for Decline Ahead of Earnings | Stock Movers
4:16
Merck Drops, Walmart Falls, Nvidia Shares Set for Decline Ahead of E…
5 views1 week ago
YouTubeBloomberg Podcasts
Merck to Buy Cidara in $9.2B Deal as Patent Deadline Looms
4:14
Merck to Buy Cidara in $9.2B Deal as Patent Deadline Looms
1 week ago
YouTubeBloomberg Podcasts
Does Merck KGaA’s Biotech Expansion Signal Opportunity After 20% Share Price Drop in 2025?
Does Merck KGaA’s Biotech Expansion Signal Opportunity Aft…
1 day ago
YahooSimply Wall St
Is Merck a MASSIVE Opportunity at a 52 Week Low? | Merck (MRK) Stock Analysis! |
12:28
Is Merck a MASSIVE Opportunity at a 52 Week Low? | Merck (MRK) St…
11.7K views9 months ago
YouTubeDividendology
Merck CEO Robert Davis on Q3 results: Our portfolio sets us up for a good finish to the year
6:04
Merck CEO Robert Davis on Q3 results: Our portfolio sets us up fo…
4.4K viewsOct 31, 2024
YouTubeCNBC Television
8:12
Merck CEO Rob Davis on FDA approval of Keytruda injection, na…
2.6K views1 month ago
YouTubeCNBC Television
0:33
Merck drug company announces $70 billion investments in the US
343 views1 month ago
YouTubeThe National Desk
2:21
Get Back
265 views2 days ago
YouTubeMerck - Topic
0:21
Trending Stocks Up to Nov 17, 2025 #Cisco #Merck
9 views4 days ago
YouTubeExclusive Markets
2:22
Drugmaker Merck opens state-of-art $1B facility to manufacture HPV G…
8 months ago
ABC11 Raleigh-DurhamCindy Bae
2:19
Delivering innovative health with generative AI solutions at Merck | …
4.6K viewsJul 26, 2023
YouTubeAmazon Web Services
0:05
Third window syndrome is a group of vestibular and auditory sympto…
1K views3 days ago
FacebookMerck Manual Professional
0:05
With classic scabies, erythematous papules initially appear in finger w…
575 views1 day ago
FacebookMerck Manual Professional
1:01
"On this ‘World Diabetes Day 2025’, I’m very excited to share with you …
63 views6 days ago
FacebookDr. Rasha Kelej
0:05
Symptoms of scabies first begin to appear around 4 to 6 weeks after i…
311 views1 day ago
FacebookMerck Manual Consumer
See more videos
Static thumbnail place holder